Cancers that are frequently associated with TERT promoter mutations include glioblastoma multiforme (GBM), melanoma, hepatocellular carcinoma, urothelial cancers, anaplastic thyroid cancer, and a variety of non-melanoma skin cancers (for review see [96]). This evidence concerns the gene TERT and melanoma.